Shopping Cart 0
Cart Subtotal
USD 0

Purdue Pharma LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) medicines and related healthcare products. Its major product categories include prescription opioids, sedatives (for sleep disorders), laxatives, antiseptics and dietary supplements. The company also conducts clinical studies on new investigational drugs and pharmaceuticals on the market. The company operates three facilities in North Carolina and New Jersey. It is a member of MundiPharma International Limited's network of independent associated companies. Purdue is headquartered in Stamford, Connecticut, the US.

Purdue Pharma LP-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Purdue Pharma LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Purdue Pharma Acquires Rights to VM-902A from VM Pharma 12

Venture Financing 13

Kolltan Pharma Raises USD 60 Million In Series D Financing 13

Partnerships 15

Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 15

University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 16

University of Nebraska Medical Center and Purdue Pharma Enter into Agreement 17

Purdue Pharma to Form Joint Venture with AnaBios 18

Eisai Enters into Agreement with Purdue Pharma 19

Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 20

ElMindA Enters Into Agreement With Purdue Pharma To Develop New Pain Drugs 22

Licensing Agreements 23

Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 23

Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 24

Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 25

Purdue Pharma Enters into Licensing Agreement with Exicure 26

Purdue Pharma Enters into Licensing agreement with AnaBios 27

Purdue Pharma Enters Into Licensing Agreement With Medical Developments 28

Helsinn Signs Licensing Agreement with Purdue Pharma Canada 29

Grunenthal Enters Into Licensing Agreement With Purdue Pharma For IP Rights To Abuse-Deterrent Formulation Technology 30

Actavis Enters Into Licensing Agreement With Purdue Pharma For Generic OxyContin 31

Acquisition 32

Purdue Pharma to Acquire SpineThera 32

Purdue Pharma LP-Key Competitors 33

Purdue Pharma LP-Key Employees 34

Purdue Pharma LP-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Recent Developments 36

Corporate Communications 36

Jul 24, 2018: Purdue Pharma announces leadership changes 36

Mar 01, 2018: Purdue Pharma L.P. Names Dr. Marcelo Bigal as Chief Medical Officer 38

Jun 22, 2017: Dr. Craig Landau Appointed President and CEO Purdue Pharma L.P. 39

Legal and Regulatory 40

Aug 02, 2018: Orland Fire joins 13 municipalities in class action suit to block Opioid addiction 40

Jun 12, 2018: Mass. Sues Purdue Pharma over 670 residents who fatally overdosed on opioids 41

Jun 08, 2018: Tenn. Attorney General Seeks to Make State's Complaint against Purdue Pharma Public 42

Feb 06, 2018: Beasley Allen files opioid lawsuit on behalf of the State of Alabama 43

May 31, 2017: Attorney General DeWine Files Lawsuit Against Opioid Manufacturers for Fraudulent Marketing; Fueling Opioid Epidemic 44

Government and Public Interest 45

Feb 09, 2018: Purdue Pharma Issues Statement on Opioid Promotion 45

Jan 31, 2018: Purdue Pharma L.P. Awards Grants to Further Research on the Assessment of Chronic Pain 46

Product News 47

Sep 04, 2018: BETADINE-A new treatment option for canadians for oral infections-now available in Canada 47

Jun 12, 2017: Consumer Research Drives New Packaging Updates for Colace and Senokot Occasional Constipation Relief Products 48

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

Purdue Pharma LP, Pharmaceuticals & Healthcare, Key Facts 2

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Purdue Pharma LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Purdue Pharma LP, Deals By Therapy Area, 2012 to YTD 2018 9

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Purdue Pharma Acquires Rights to VM-902A from VM Pharma 12

Kolltan Pharma Raises USD 60 Million In Series D Financing 13

Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 15

University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 16

University of Nebraska Medical Center and Purdue Pharma Enter into Agreement 17

Purdue Pharma to Form Joint Venture with AnaBios 18

Eisai Enters into Agreement with Purdue Pharma 19

Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 20

ElMindA Enters Into Agreement With Purdue Pharma To Develop New Pain Drugs 22

Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 23

Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 24

Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 25

Purdue Pharma Enters into Licensing Agreement with Exicure 26

Purdue Pharma Enters into Licensing agreement with AnaBios 27

Purdue Pharma Enters Into Licensing Agreement With Medical Developments 28

Helsinn Signs Licensing Agreement with Purdue Pharma Canada 29

Grunenthal Enters Into Licensing Agreement With Purdue Pharma For IP Rights To Abuse-Deterrent Formulation Technology 30

Actavis Enters Into Licensing Agreement With Purdue Pharma For Generic OxyContin 31

Purdue Pharma to Acquire SpineThera 32

Purdue Pharma LP, Key Competitors 33

Purdue Pharma LP, Key Employees 34

Purdue Pharma LP, Other Locations 35

Purdue Pharma LP, Subsidiaries 35

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) medicines and related healthcare products. Its major product categories include prescription opioids, sedatives (for sleep disorders), laxatives, antiseptics and dietary supplements. The company also conducts clinical studies on new investigational drugs and pharmaceuticals on the market. The company operates three facilities in North Carolina and New Jersey. It is a member of MundiPharma International Limited's network of independent associated companies. Purdue is headquartered in Stamford, Connecticut, the US.

Purdue Pharma LP-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Purdue Pharma LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Purdue Pharma Acquires Rights to VM-902A from VM Pharma 12

Venture Financing 13

Kolltan Pharma Raises USD 60 Million In Series D Financing 13

Partnerships 15

Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 15

University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 16

University of Nebraska Medical Center and Purdue Pharma Enter into Agreement 17

Purdue Pharma to Form Joint Venture with AnaBios 18

Eisai Enters into Agreement with Purdue Pharma 19

Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 20

ElMindA Enters Into Agreement With Purdue Pharma To Develop New Pain Drugs 22

Licensing Agreements 23

Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 23

Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 24

Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 25

Purdue Pharma Enters into Licensing Agreement with Exicure 26

Purdue Pharma Enters into Licensing agreement with AnaBios 27

Purdue Pharma Enters Into Licensing Agreement With Medical Developments 28

Helsinn Signs Licensing Agreement with Purdue Pharma Canada 29

Grunenthal Enters Into Licensing Agreement With Purdue Pharma For IP Rights To Abuse-Deterrent Formulation Technology 30

Actavis Enters Into Licensing Agreement With Purdue Pharma For Generic OxyContin 31

Acquisition 32

Purdue Pharma to Acquire SpineThera 32

Purdue Pharma LP-Key Competitors 33

Purdue Pharma LP-Key Employees 34

Purdue Pharma LP-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Recent Developments 36

Corporate Communications 36

Jul 24, 2018: Purdue Pharma announces leadership changes 36

Mar 01, 2018: Purdue Pharma L.P. Names Dr. Marcelo Bigal as Chief Medical Officer 38

Jun 22, 2017: Dr. Craig Landau Appointed President and CEO Purdue Pharma L.P. 39

Legal and Regulatory 40

Aug 02, 2018: Orland Fire joins 13 municipalities in class action suit to block Opioid addiction 40

Jun 12, 2018: Mass. Sues Purdue Pharma over 670 residents who fatally overdosed on opioids 41

Jun 08, 2018: Tenn. Attorney General Seeks to Make State's Complaint against Purdue Pharma Public 42

Feb 06, 2018: Beasley Allen files opioid lawsuit on behalf of the State of Alabama 43

May 31, 2017: Attorney General DeWine Files Lawsuit Against Opioid Manufacturers for Fraudulent Marketing; Fueling Opioid Epidemic 44

Government and Public Interest 45

Feb 09, 2018: Purdue Pharma Issues Statement on Opioid Promotion 45

Jan 31, 2018: Purdue Pharma L.P. Awards Grants to Further Research on the Assessment of Chronic Pain 46

Product News 47

Sep 04, 2018: BETADINE-A new treatment option for canadians for oral infections-now available in Canada 47

Jun 12, 2017: Consumer Research Drives New Packaging Updates for Colace and Senokot Occasional Constipation Relief Products 48

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

Purdue Pharma LP, Pharmaceuticals & Healthcare, Key Facts 2

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Purdue Pharma LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Purdue Pharma LP, Deals By Therapy Area, 2012 to YTD 2018 9

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Purdue Pharma Acquires Rights to VM-902A from VM Pharma 12

Kolltan Pharma Raises USD 60 Million In Series D Financing 13

Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 15

University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 16

University of Nebraska Medical Center and Purdue Pharma Enter into Agreement 17

Purdue Pharma to Form Joint Venture with AnaBios 18

Eisai Enters into Agreement with Purdue Pharma 19

Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 20

ElMindA Enters Into Agreement With Purdue Pharma To Develop New Pain Drugs 22

Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 23

Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 24

Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 25

Purdue Pharma Enters into Licensing Agreement with Exicure 26

Purdue Pharma Enters into Licensing agreement with AnaBios 27

Purdue Pharma Enters Into Licensing Agreement With Medical Developments 28

Helsinn Signs Licensing Agreement with Purdue Pharma Canada 29

Grunenthal Enters Into Licensing Agreement With Purdue Pharma For IP Rights To Abuse-Deterrent Formulation Technology 30

Actavis Enters Into Licensing Agreement With Purdue Pharma For Generic OxyContin 31

Purdue Pharma to Acquire SpineThera 32

Purdue Pharma LP, Key Competitors 33

Purdue Pharma LP, Key Employees 34

Purdue Pharma LP, Other Locations 35

Purdue Pharma LP, Subsidiaries 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS